Obstetrics/Gynecology
RSSArticles
-
The WAVE Trial — More of the Same
The Womens Angiographic Vitamin and Estrogen (WAVE) Trial was a randomized, controlled secondary prevention study. This study enrolled 423 postmenopausal women with coronary atherosclerosis already established at baseline by angiography. -
Pharmacology Watch: FDA Approves Claritin For OTC Use For Seasonal Rhinitis
After years of legal wrangling, the FDA has approved loratadine (Claritin, Schering-Plough) as an over-the-counter (OTC) product for the treatment of seasonal rhinitis. -
Full January 1, 2003 Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Alcohol and Hormone Therapy Increase the Risk of Breast Cancer
Synopsis: The Nurses Health Study reports an increased incidence of breast cancer with daily alcohol consumption, hormone therapy, and an additive effect with greater drinking. -
A Modern Day Faustus: COX-2 Inhibitors — Are We Trading Gastric Protection for Cardiac Death?
This study suggests that high-dose rofecoxib may increase the risk of cardiovascular events. -
Full December 15, 2002, Issue in PDF
-
Pharmacology Watch: FDA Approves Generic Version of AstraZeneca’s Prilosec
The FDA has approved the first generic version of AstraZeneca plcs blockbuster drug, omeprazole (Prilosec). -
ECG Review: What’s Going On? (Part II)
The 12-lead ECG and accompanying rhythm strip in the Figure were obtained from an 84-year-old man who presented to the Emergency Department with acute dyspnea from pneumonia and heart failure. Can you account for the relatively slow heart rate despite his acute shortness of breath? -
Clinical Briefs
Effects of Long-Term Treatment With ACE Inhibitors in the Presence or Absence of Aspirin; Long-Term Risks Associated with Atrial Fibrillation: 20-Year Follow-up of the Renfrew/Paisley Study; Olfactory Impairment in Older Adults